Yu Jia

Chinese Academy of Sciences

H指数:14

被引数:502

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The aggregation of amyloid-β: from condensation, nucleation, and conformation to targeting therapy

淀粉样蛋白-β的聚集：从凝聚、成核和构象到靶向治疗

Life Sciences

IF5.1

2026-04-150

OAAI

Association between family support and 6-months functional recovery in acute ischemic stroke patients: a prospective cohort study

家庭支持与急性缺血性卒中患者6个月功能恢复的关联：一项前瞻性队列研究

Frontiers in Medicine

IF3

2025-12-180

OAAI

Net health benefit of mavacamten for the treatment of Chinese patients with obstructive hypertrophic cardiomyopathy: a model-based economic evaluation

mavacamten治疗中国梗阻性肥厚型心肌病患者的净健康效益：基于模型的经济评价

Frontiers in Pharmacology

IF4.8

2025-10-310

OAAI

Impact Factors for Trajectories of Medication and Healthy Lifestyle Adherence in Young Adults With Hypertension: A Mixed Methods Study

高血压青年患者药物治疗和健康生活方式依从性轨迹的影响因素：一项混合方法研究

clinical hypertension

IF0

2025-08-070

OAAI

Reply to ‘Methodological Considerations and Future Directions in Cardiac Geometry Assessment for Cirrhotic Cardiomyopathy’

回复‘肝硬变心肌病中心脏几何形态评估的方法学考量与未来方向’

Liver International

IF5.2

2025-06-300

PRE

Digital biomarkers for real-life, home-based monitoring of frailty: a systematic review and meta-analysis

真实生活、居家环境下的衰弱状态监测数字生物标志物：一项系统评价和Meta分析

AGE AND AGEING

IF7.1

2025-04-190

PRE

Periodontal diseases, potential mediators and development of liver fat content: a community-based large cohort

牙周疾病、潜在介导因素与肝脏脂肪含量发展：一项基于社区的大规模队列研究

FRONTIERS IN MEDICINE

IF3

2025-04-090

Photocaging of N-pyridinyl amide scaffold-based PIM inhibitors for spatiotemporal controlled anticancer bioactivity

基于N-吡啶基酰胺支架的PIM抑制剂的光老化，用于时空控制的抗癌生物活性

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2025-04-010

PRE

Prognostic Implications of Cardiac Geometry in Cirrhosis: Findings From a Large Cohort

LIVER INTERNATIONAL

IF5.2

2025-01-030

PRE

Knowledge, attitudes, and practices of family caregivers for patients with cerebral infarction toward home-based care

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-08-200

OAAI

Systemic inflammation in midlife is associated with late-life functional limitations

SCIENTIFIC REPORTS

IF3.9

2024-07-290

OAAI

Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm

代谢功能障碍相关性脂肪肝与腹主动脉瘤的关系

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

IF3.7

2024-04-014

PRE

Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171

通过优化针对Lys67和Asp128/Glu171的片段，发现基于N-吡啶基酰胺支架的用于急性髓性白血病的高效PIM激酶抑制剂

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-09-013

PRE

Evaluation of a novel scoring system based on thrombosis and inflammation for predicting stroke-associated pneumonia: A retrospective cohort study

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2023-03-301

OAAI

Nutritional risk screening 2002 scale and subsequent risk of stroke-associated infection in ischemic stroke: The REMISE study

FRONTIERS IN NUTRITION

IF5.1

2022-09-0912

OAAI

NDDRF: A risk factor knowledgebase for personalized prevention of neurodegenerative diseases

JOURNAL OF ADVANCED RESEARCH

IF13

2022-09-019

OAAI

Cognition impairment and risk of subclinical cardiovascular disease in older adults: The atherosclerosis risk in communities study

老年人认知障碍与亚临床心血管疾病风险: 社区动脉粥样硬化风险研究

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2022-07-274

OAAI

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study

BMC GERIATRICS

IF3.8

2022-04-1211

OAAI

Adherence to Healthy Lifestyle and the Risk of Function Limitations in Late Life: The Atherosclerosis Risk in Communities Study

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2021-08-037

OAAI

Adherence to a Healthy Lifestyle and the Risk of All-Cause Mortality and Cardiovascular Events in Individuals With Diabetes: The ARIC Study

FRONTIERS IN NUTRITION

IF5.1

2021-07-059

OAAI

Yu Jia

个人简介

教育背景

工作经历

荣誉奖项

研究方向